Market Overview

Global Peptide Therapeutics Market Analysis 2017-2018 - Forecast to 2025 -


The "Global
Peptide Therapeutics Market Analysis 2017 - Forecast to 2025"

report has been added to's

The report contains up to date financial data derived from varied
research sources to present unique and reliable analysis. Assessment of
major trends with potential impact on the market during the next five
years, including a deep dive analysis of market segmentation which
comprises of sub markets, regional and country level analysis. The
report provides a comprehensive outlook about the market share along
with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights.
The market assessment is performed through standard and the tailored
research methodology approach. The market overview offers in depth
analysis at the regional and country level.

Annual estimations and forecasts are provided from the year 2014 to 2025
for each given segment and sub segments. Market data derived from the
authenticated and reliable sources is subjected to validation from the
industry experts. The report also analyzes the market by discussing
market dynamics such as drivers, constraints, opportunities, threats,
challenges and other market trends.

Competitive landscaping provides the recent activities performed by the
active players in the market. Activities such as product launch,
agreements, joint ventures, partnerships, acquisitions and mergers, and
other activities.

Key Topics Covered

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Peptide Therapeutics Market by Type of Molecule

6 Peptide Therapeutics Market by Route of Administration

7 Peptide Therapeutics Market by Application

8 Peptide Therapeutics Market by Technology

9 Peptide Therapeutics Market by Type of Manufacturers

10 Peptide Therapeutics Market by Type

11 Geographical Segmentation

12 Vendor Landscaping

13 Company Profiles

  • Bachem Holding AG
  • Sanofi
  • Hoffmann-La Roche Ltd.
  • Novartis AG
  • GlaxoSmithKline
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bachem Holding AG
  • Takeda Pharmaceutical Company Limited
  • Amgen, Inc.
  • Eli Lilly and Company
  • Lonza Inc.
  • Bristol-Myers Squibb (BMS)
  • AstraZeneca PLC
  • Novo Nordisk A/S

For more information about this report visit

View Comments and Join the Discussion!